PRME:NASDAQ
Prime Medicine, Inc
$3.13
arrow_downward
-6.57%(-0.22) 1D
$3.18
arrow_upward
+1.56% (+0.049)bedtimeAfter hours
Closed: Sep 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRME...
Open
$3.38
High
$3.44
Low
$3.10
Mkt. cap
567.71M
Avg. vol.
2.66M
Volume
3.08M
52-wk high
$6.94
52-wk low
$2.67
EPS
-$1.09
Beta
2.34
Shares outstanding
181.38M
No. of employees
146
Open
$3.38
High
$3.44
Low
$3.10
Mkt. cap
567.71M
Avg. vol.
2.66M
Volume
3.08M
52-wk high
$6.94
52-wk low
$2.67
EPS
-$1.09
Beta
2.34
Shares outstanding
181.38M
No. of employees
146
News stories
From web sources and news partners
MarketBeat
·
21 hours ago
Prime Medicine (NASDAQ:PRME) Rating Increased to Hold at Wall Street Zen
Profile
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts. Wikipedia
About Prime Medicine, Inc